Article
COL3A1 haploinsufficiency results in a variety of Ehlers-Danlos syndrome type IV with delayed onset of complications and longer life expectancy.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Aug 2011
Leistritz Dru F, Pepin Melanie G, Schwarze Ulrike, Byers Peter H
Abstract excerpt
PURPOSE: To characterize the clinical outcome of heterozygosity for COL3A1 null mutations in Ehlers-Danlos syndrome type IV, the vascular type. METHODS: We identified mutations that produced premature termination codons and resulted in nonsense-mediated messenger RNA decay in 19 families. We reviewed the clinical and family histories and medical complications in 54 individuals from these families with COL3A1 null...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
